ReShape Lifesciences Inc.

CIK 1371217 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ReShape Lifesciences Inc..

Recent SEC filings

FiledFormAccession number
Jun 25, 2021EFFECT9999999995-21-002518
Jun 25, 2021EFFECT9999999995-21-002524
Jun 25, 2021EFFECT9999999995-21-002522
Jun 25, 2021EFFECT9999999995-21-002520
Jun 25, 2021EFFECT9999999995-21-002517
Jun 25, 2021EFFECT9999999995-21-002523
Jun 25, 2021EFFECT9999999995-21-002521
Jun 25, 2021EFFECT9999999995-21-002516
Jun 25, 2021EFFECT9999999995-21-002519
Jun 25, 2021EFFECT9999999995-21-002515
Jun 22, 2021S-8 POS0001104659-21-084108
Jun 22, 2021POS AM0001104659-21-084095
Jun 22, 2021S-8 POS0001104659-21-084112
Jun 22, 2021S-8 POS0001104659-21-084106
Jun 22, 2021POS AM0001104659-21-084081
Jun 22, 2021S-8 POS0001104659-21-084104
Jun 22, 2021POS AM0001104659-21-084097
Jun 22, 2021POS AM0001104659-21-084086
Jun 22, 202140000919574-21-004187
Jun 22, 2021S-8 POS0001104659-21-084102
Jun 22, 2021POS AM0001104659-21-084093
Jun 22, 2021POS AM0001104659-21-084101
Jun 22, 202115-12B0001104659-21-084121
Jun 22, 2021POS AM0001104659-21-084084
Jun 22, 2021S-8 POS0001104659-21-084107